Vikas Lifecare quarterly results

Q4 FY26 · Jan–Mar 2026

₹ crore	Q4 FY26	Q4 FY25	Change
Revenue	169	135	+24.7%
EBITDA	−26.3	−19.6	—
EBITDA margin	−15.6%	−14.5%	−1.1 pts
Profit before tax	−28.4	−5.2	—
Net profit	41.6	−2.8	—
EPS	₹0.22	−₹0.02	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Q1 FY24Jun 2023	Q4 FY23Mar 2023	Earlier quartersAlpha Plus

Expenses
	169	97.0	141	135	118	135	92.1	132	99.3	116	98.9	118	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	0.9	0.7	0.9	21.1	−0.7	3.3	2.2	4.7	3.1	6.7	11.6	−31.8
	170	97.8	142	156	117	138	94.3	136	102	123	111	86.3
	5.9	8.2	2.9	4.4	5.3	5.5	1.9	6.7	−3.2	6.8	5.1	18.5
	157	81.7	137	122	113	126	87.7	103	110	93.3	90.2	93.0
	0.3	2.9	−1.1	4.6	−3.0	−1.8	−0.6	10.8	−9.5	7.4	−1.8	1.6
	1.0	1.0	1.1	1.1	1.2	1.1	1.0	2.1	1.5	1.6	0.6	−0.7
	1.6	2.0	1.8	1.5	1.4	1.0	0.7	1.3	0.6	0.7	0.5	1.2
	1.4	1.5	1.5	2.1	1.5	1.8	1.3	1.3	0.8	0.7	0.9	0.7
	31.2	18.8	5.2	23.1	3.3	3.5	2.4	4.5	5.1	4.4	2.2	4.4
	198	116	148	158	123	137	94.3	130	105	115	97.6	119
	−26.3	−15.6	−3.6	−19.6	−2.1	0.4	−0.2	4.1	−4.8	2.5	2.7	1.3
	−27.7	−17.2	−5.1	−21.7	−3.6	−1.5	−1.6	2.8	−5.6	1.8	1.8	0.6
Profit
	−28.4	−18.4	−6.1	−2.1	−5.7	0.8	0.0	6.3	−3.0	7.8	12.9	−32.4
	0.0	−14.8	−114	−3.2	−1.1	−1.7	0.0	−6.9	0.0	0.0	0.0	0.0
	−28.4	−33.2	−120	−5.2	−6.8	−0.9	0.0	−0.6	−3.0	7.8	12.9	−32.4
	−0.1	0.1	−0.1	1.0	2.6	−2.6	2.9	0.3	0.9	0.2	1.2	2.7
	−6.2	−4.0	−1.0	−3.4	−2.5	−0.4	0.0	1.1	−0.0	0.0	0.0	−8.2
	−6.3	−3.9	−1.1	−2.4	0.0	−3.0	2.9	1.4	0.9	0.2	1.2	−5.5
	63.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	41.6	−29.3	−119	−2.8	−6.9	2.2	−2.9	−2.0	−3.9	7.7	11.7	−26.8
	−22.1	−29.3	−119	−2.8	−6.9	2.2	−2.9	−2.0	−3.9	7.7	11.7	−26.9
	1.0	−0.4	0.4	−0.5	−0.1	4.3	0.1	−2.3	−0.2	0.8	0.4	−2.0
	42.6	−29.6	−119	−3.3	−6.9	6.4	−2.9	−4.4	−4.1	8.5	12.1	−28.8
	41.6	−29.2	—	—	−6.8	2.2	−2.8	−1.8	−3.5	7.3	—	−26.9
	0.0	−0.1	—	0.0	−0.0	0.0	−0.1	−0.2	−0.4	0.3	0.0	0.1
Per share
	₹0.22	−₹0.16	−₹0.64	−₹0.02	−₹0.04	₹0.03	—	−₹0.03	−₹0.03	₹0.06	₹0.08	−₹0.19
	₹0.22	−₹0.16	−₹0.64	−₹0.02	−₹0.04	₹0.03	—	−₹0.03	−₹0.03	₹0.06	₹0.08	−₹0.19
Other comprehensive income — detail
	1.0	−0.4	0.4	−0.5	—	—	—	—	—	—	—	—
	—	—	—	—	—	—	0.1	−3.1	−0.3	1.1	0.5	−2.8
	−1.0	0.4	−0.4	0.5	—	—	—	—	—	—	—	—
	—	—	—	—	0.1	−5.7	0.0	−0.8	−0.1	0.3	0.1	−0.8
	—	—	—	—	—	—	−0.0	—	0.0	−0.0	—	−0.0
	—	—	—	—	0.0	1.4	−0.0	0.0	0.0	−0.0	0.0	−0.0
	42.5	−29.6	—	−3.3	−6.8	6.4	−2.8	—	−3.7	8.2	—	−28.9
	0.0	−0.1	—	—	−0.0	0.0	0.1	—	−0.4	0.3	—	0.1
Per share — as-filed variants
	₹0.22	−₹0.16	−₹0.64	−₹0.02	−₹0.04	₹0.03	₹0.00	−₹0.03	−₹0.03	₹0.06	₹0.08	−₹0.19
	₹0.22	−₹0.16	−₹0.64	−₹0.02	−₹0.04	₹0.03	₹0.00	−₹0.03	−₹0.03	₹0.06	₹0.08	−₹0.19
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	5.9	4.2	2.7	4.7	2.3	4.9	3.1	10.7	1.8	8.6	5.4	5.0
	3.5%	4.3%	1.9%	3.4%	2.0%	3.7%	3.4%	8.1%	1.8%	7.4%	5.5%	4.2%
Adjusted (ex-exceptional items) — derived
	−28.4	−18.4	−6.1	−2.1	−5.7	0.8	0.0	6.3	−3.0	7.8	12.9	−32.4
	0.0	−14.8	−114	−3.2	−1.1	−1.7	0.0	−6.9	0.0	0.0	0.0	0.0
	41.6	−16.2	−6.0	−1.1	−5.8	2.8	−2.9	4.9	−3.9	7.7	11.7	−26.8
	₹0.22	−₹0.09	−₹0.03	−₹0.01	−₹0.03	₹0.04	—	₹0.07	−₹0.03	₹0.06	₹0.08	−₹0.19

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

VIKASLIFE₹1.12

Vikas Lifecare Limited

· Consumer Services

Annual Quarterly₹ CrorePeersSAKUMA ESSENTIA KOTHARIPRO ANIKINDS OSWALAGRO LANDSMILL GOYALALUM STCINDIAMcap ₹208 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q4 FY23 31/03/2023	Q1 FY24 30/06/2023	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026
Revenue from Operations	118.1	98.9	116.0	99.3	131.5	92.1	134.9	117.8	135.2	141.3	97.0	168.6
Other Income	-31.8	11.6	6.7	3.1	4.7	2.2	3.3	-0.7	21.1	0.9	0.7	0.9
Total Income	86.3	110.5	122.7	102.4	136.3	94.3	138.2	117.1	156.3	142.2	97.8	169.5
Expenses
+ Cost of Materials Consumed	18.5	5.1	6.8	-3.2	6.7	1.9	5.5	5.3	4.4	2.9	8.2	5.9
+ Purchases of Stock-in-Trade	93.0	90.2	93.3	110.2	103.4	87.7	126.2	113.2	121.6	136.8	81.7	156.6
+ Changes in Inventories	1.6	-1.8	7.4	-9.5	10.8	-0.6	-1.8	-3.0	4.6	-1.1	2.9	0.3
+ Employee Benefit Expense	-0.7	0.6	1.6	1.5	2.1	1.0	1.1	1.2	1.1	1.1	1.0	1.0
+ Finance Costs	1.2	0.5	0.7	0.6	1.3	0.7	1.0	1.4	1.5	1.8	2.0	1.6
+ Depreciation & Amortisation	0.7	0.9	0.7	0.8	1.3	1.3	1.8	1.5	2.1	1.5	1.5	1.4
+ Other Expenses	4.4	2.2	4.4	5.1	4.5	2.4	3.5	3.3	23.1	5.2	18.8	31.2
Total Expenses	118.7	97.6	114.9	105.4	130.0	94.3	137.4	122.9	158.4	148.3	116.2	197.9
EBITDA	1.3	2.7	2.5	-4.8	4.1	-0.2	0.4	-2.1	-19.6	-3.6	-15.6	-26.3
EBIT	0.6	1.8	1.8	-5.6	2.8	-1.6	-1.5	-3.6	-21.7	-5.1	-17.2	-27.7
Profit
PBT before Exceptional Items	-32.4	12.9	7.8	-3.0	6.3	0.0	0.8	-5.7	-2.1	-6.1	-18.4	-28.4
+ Exceptional Items	0.0	0.0	0.0	0.0	-6.9	0.0	-1.7	-1.1	-3.2	-114.0	-14.8	0.0
Pretax Income	-32.4	12.9	7.8	-3.0	-0.6	0.0	-0.9	-6.8	-5.2	-120.1	-33.2	-28.4
+ Current Tax	2.7	1.2	0.2	0.9	0.3	2.9	-2.6	2.6	1.0	-0.1	0.1	-0.1
+ Deferred Tax	-8.2	0.0	0.0	-0.0	1.1	0.0	-0.4	-2.5	-3.4	-1.0	-4.0	-6.2
Tax Expense	-5.5	1.2	0.2	0.9	1.4	2.9	-3.0	0.0	-2.4	-1.1	-3.9	-6.3
+ Share of Associates & JVs	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.7
Net Income	-26.8	11.7	7.7	-3.9	-2.0	-2.9	2.2	-6.9	-2.8	-119.0	-29.3	41.6
+ Net Income — Continuing Ops	-26.9	11.7	7.7	-3.9	-2.0	-2.9	2.2	-6.9	-2.8	-119.0	-29.3	-22.1
+ Other Comprehensive Income	-2.0	0.4	0.8	-0.2	-2.3	0.1	4.3	-0.1	-0.5	0.4	-0.4	1.0
Total Comprehensive Income	-28.8	12.1	8.5	-4.1	-4.4	-2.9	6.4	-6.9	-3.3	-118.6	-29.6	42.6
Net Income to Common	-26.9	—	7.3	-3.5	-1.8	-2.8	2.2	-6.8	—	—	-29.2	41.6
Minority Interest	0.1	0.0	0.3	-0.4	-0.2	-0.1	0.0	-0.0	0.0	—	-0.1	0.0
Per Share
Basic EPS	-0.19	0.08	0.06	-0.03	-0.03	—	0.03	-0.04	-0.02	-0.64	-0.16	0.22
Diluted EPS	-0.19	0.08	0.06	-0.03	-0.03	—	0.03	-0.04	-0.02	-0.64	-0.16	0.22
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	—	—	-0.5	0.4	-0.4	1.0
+ Items NOT to be Reclassified to P&L	-2.8	0.5	1.1	-0.3	-3.1	0.1	—	—	—	—	—	—
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	—	—	0.5	-0.4	0.4	-1.0
+ Tax on Items NOT to be Reclassified — alt tag	-0.8	0.1	0.3	-0.1	-0.8	0.0	-5.7	0.1	—	—	—	—
+ Items to be Reclassified to P&L	-0.0	—	-0.0	0.0	—	-0.0	—	—	—	—	—	—
+ Tax on Items to be Reclassified — alt tag	-0.0	0.0	-0.0	0.0	0.0	-0.0	1.4	0.0	—	—	—	—
Comprehensive Income — Owners of Parent	-28.9	—	8.2	-3.7	—	-2.8	6.4	-6.8	-3.3	—	-29.6	42.5
Comprehensive Income — Non-controlling Interests	0.1	—	0.3	-0.4	—	0.1	0.0	-0.0	—	—	-0.1	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	-0.19	0.08	0.06	-0.03	-0.03	0.00	0.03	-0.04	-0.02	-0.64	-0.16	0.22
Diluted EPS — Continuing Operations	-0.19	0.08	0.06	-0.03	-0.03	0.00	0.03	-0.04	-0.02	-0.64	-0.16	0.22
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	5.0	5.4	8.6	1.8	10.7	3.1	4.9	2.3	4.7	2.7	4.2	5.9
Gross Margin %	4.20	5.47	7.40	1.84	8.11	3.37	3.66	1.97	3.45	1.90	4.34	3.47
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-32.4	12.9	7.8	-3.0	6.3	0.0	0.8	-5.7	-2.1	-6.1	-18.4	-28.4
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	-6.9	0.0	-1.7	-1.1	-3.2	-114.0	-14.8	0.0
Net Income Adj (tax-effected)	-26.8	11.7	7.7	-3.9	4.9	-2.9	2.8	-5.8	-1.1	-6.0	-16.2	41.6
EPS Adj	-0.19	0.08	0.06	-0.03	0.07	—	0.04	-0.03	-0.01	-0.03	-0.09	0.22
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	—	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	143.9	—	143.9	143.9	165.2	186.0	186.0	186.0	186.0	186.0	186.0	186.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q4 FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.